Mycifradin Side Effects
Generic Name: neomycin
Note: This document contains side effect information about neomycin. Some of the dosage forms listed on this page may not apply to the brand name Mycifradin.
For the Consumer
Applies to neomycin: oral solution, oral tablet
Along with its needed effects, neomycin (the active ingredient contained in Mycifradin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking neomycin:
- Any loss of hearing
- difficulty in breathing
- greatly decreased frequency of urination or amount of urine
- increased amount of gas
- increased thirst
- light-colored, frothy, fatty-appearing stools
- ringing or buzzing or a feeling of fullness in the ears
- skin rash
Some side effects of neomycin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
For Healthcare Professionals
Applies to neomycin: compounding powder, oral solution, oral tablet
The most commonly reported side effects included diarrhea, nausea, and vomiting.[Ref]
Common (1% to 10%): Diarrhea, nausea, vomiting
Metabolic syndrome occurred with prolonged therapy, and included increased fecal fat, steatorrhea, decreased serum carotene, and a fall in xylose absorption. Steatorrhea and diarrhea occurring during metabolic syndrome can be very severe.[Ref]
Frequency not reported: Neuromuscular blockade/blockage, neurotoxicity, nystagmus, paresthesia, vestibular toxicity[Ref]
Frequency not reported: Drug fever, ototoxicity, permanent bilateral ototoxicity[Ref]
Frequency not reported: Increased bilirubin levels, increased hepatic enzyme levels[Ref]
Frequency not reported: Confusion, disorientation[Ref]
Frequency not reported: Nephrotoxicity[Ref]
Superinfection occurred with prolonged therapy.[Ref]
Frequency not reported: Superinfection[Ref]
Frequency not reported: Respiratory paralysis[Ref]
1. "Product Information. Mycifradin (neomycin)." Emerson Laboratories, Texarkana, TX.
2. "Product Information. Neomycin (neomycin)" Pharma-Tek, Huntington, NY.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.